NINTH INTERNATIONAL CONFERENCE ON GENE THERAPY OF CANCER

拟议中的会议是专门讨论癌症基因治疗的第九次国际会议。来自世界各地的领先研究人员将展示他们使用基因治疗技术治疗癌症的基础研究、临床前和临床研究的最新结果。该计划的设计包括侧重于治疗耐药和致敏基因治疗的会议；肿瘤抑制、细胞凋亡、血管生成和抗癌基因治疗；以及细胞因子和肿瘤免疫治疗。每个专题会议将以人体临床试验的领域和现状的概述开始。此外，还将举办一个关于矢量系统和目标的研讨会。特邀演讲者之后将介绍介绍最近的基础研究、临床前和临床数据的摘要。下午将专门进行讨论，并从提交的摘要中添加口头和海报演示文稿。临床肿瘤学家、分子生物学家、细胞生物学家、肿瘤免疫学家和其他在该领域工作的感兴趣的卫生专业人员和研究人员将对这次会议感兴趣。

The proposed conference is the ninth international conference devoted exclusively to gene therapy of cancer. Leading researchers from around the world will present the latest results of their basic research, pre-clinical and clinical studies of cancer treatment using gene therapy technology. The design of the program includes sessions focusing on treatment resistance and sensitization gene therapy; tumor suppressor, apoptosis, angiogenesis and anti-oncogene therapy; and cytokine and tumor immunotherapy. Each topic session will begin with an overview of the field and the current status of human clinical trials. Also featured will be a workshop on vector systems and targeting. Invited speakers will be followed by the presentation of proffered abstracts describing recent basic research, pre- clinical, and clinical data. There will be an afternoon devoted to discussion sessions with additional oral and poster presentations from submitted abstracts. This conference will be of interest to clinical oncologists, molecular biologists, cellular biologists, tumor immunologists and other interested health professionals and researchers working in this field.